Northpointe Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | $2.29M | Sell |
7,874
-451
| -5% | -$131K | 0.89% | 59 |
|
2019
Q2 | $2.45M | Buy |
8,325
+706
| +9% | +$207K | 0.78% | 65 |
|
2019
Q1 | $2.09M | Sell |
7,619
-4,648
| -38% | -$1.27M | 0.66% | 70 |
|
2018
Q4 | $2.75M | Sell |
12,267
-260
| -2% | -$58.2K | 0.62% | 64 |
|
2018
Q3 | $3.06M | Sell |
12,527
-131
| -1% | -$32K | 0.44% | 108 |
|
2018
Q2 | $2.62M | Buy |
+12,658
| New | +$2.62M | 0.35% | 132 |
|
2018
Q1 | – | Sell |
-15,064
| Closed | -$2.86M | – | 189 |
|
2017
Q4 | $2.86M | Sell |
15,064
-311
| -2% | -$59K | 0.32% | 135 |
|
2017
Q3 | $2.91M | Sell |
15,375
-1,884
| -11% | -$356K | 0.31% | 131 |
|
2017
Q2 | $3.01M | Buy |
17,259
+754
| +5% | +$132K | 0.32% | 128 |
|
2017
Q1 | $2.54M | Hold |
16,505
| – | – | 0.28% | 136 |
|
2016
Q4 | $2.33M | Sell |
16,505
-465
| -3% | -$65.6K | 0.23% | 141 |
|
2016
Q3 | $2.7M | Buy |
16,970
+722
| +4% | +$115K | 0.28% | 135 |
|
2016
Q2 | $2.4M | Buy |
+16,248
| New | +$2.4M | 0.28% | 124 |
|
2016
Q1 | – | Sell |
-25,610
| Closed | -$3.13M | – | 266 |
|
2015
Q4 | $3.13M | Hold |
25,610
| – | – | 0.41% | 85 |
|
2015
Q3 | $3.13M | Buy |
25,610
+2,571
| +11% | +$314K | 0.41% | 86 |
|
2015
Q2 | $2.99M | Buy |
23,039
+3,814
| +20% | +$495K | 0.35% | 90 |
|
2015
Q1 | $2.58M | Buy |
19,225
+1,415
| +8% | +$190K | 0.28% | 121 |
|
2014
Q4 | $2.23M | Buy |
17,810
+1,508
| +9% | +$189K | 0.27% | 133 |
|
2014
Q3 | $1.98M | Buy |
16,302
+92
| +0.6% | +$11.2K | 0.21% | 139 |
|
2014
Q2 | $1.91M | Buy |
16,210
+6,623
| +69% | +$782K | 0.18% | 157 |
|
2014
Q1 | $1.15M | Sell |
9,587
-1,023
| -10% | -$123K | 0.12% | 177 |
|
2013
Q4 | $1.18M | Sell |
10,610
-260
| -2% | -$28.9K | 0.1% | 184 |
|
2013
Q3 | $1M | Buy |
+10,870
| New | +$1M | 0.12% | 184 |
|